东紫苏多酚提取物对HepG2细胞氧化损伤的保护作用研究

目的测定东紫苏（Elsholtzia bodinieri Vaniot）多酚提取物的抗氧化活性,并研究其对H2O2诱导的HepG2细胞氧化应激损伤的保护作用。方法采用福林酚(Folin-Ciocalte)法测定东紫苏提取物的多酚含量,通过测定1,1-二苯基-2-苦基肼(1,1-diphenyl-2-picrylhydrazyl,DPPH)自由基清除能力（DPPH radical scavenging activity,DRSA）、铁离子还原/抗氧化能力（ferric reducing antioxidant power,FRAP）、过氧化氢清除活性（hydrogen peroxide scavenging activity,HPSA）和总抗氧化能力（trolox equivalent antioxidant capacity,TEAC）来评价东紫苏多酚体外抗氧化活性,用MTT法测定不同浓度的东紫苏多酚对HepG2细胞的毒性作用,并确定3个无毒性作用浓度,研究其对HepG2细胞增殖抑制作用,以800 μmol/L的H2O2诱导HepG2细胞建立氧化应激损伤模型,通过测定HepG2细胞中活性氧（reactive oxygen species,ROS）含量、抗氧化酶（superoxide dismutase,SOD;catalase,CAT）活力、谷胱甘肽（glutathione, GSH）含量以及丙二醛（malonicdialdehyde,MDA）含量的变化情况,研究在5.00、2.50和1.25μg/mL无毒性作用浓度下东紫苏多酚对HepG2细胞氧化损伤的保护作用。结果东紫苏多酚含量为（30.91±1.33）μmol/g DW,DRSA值为（17.45±0.54） μmol/g DW,FRAP值为（52.64±0.05） μmol/g DW,HPSA值为（27.12±0.17）μmol/g DW,TEAC值为（186.45±0.16）μmol/g DW。东紫苏多酚提取物能使受氧化损伤的HepG2细胞内ROS和MDA含量明显减少,并且能提高受氧化损伤细胞内GSH含量以及SOD和CAT活力。结论东紫苏多酚提取物具有较好的体外抗氧化活性,对HepG2细胞氧化应激损伤具有一定的保护作用。     

Effect of coffee melanoidin on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide

Soluble high-molecular weight fraction (named melanoidin) from coffee brew was isolated by ultrafiltration, subsequently digested by simulating a gastric plus pancreatic digestive condition and partly characterized by CZE, gel-filtration and browning. The objective of the present study was to investigate the potential protective effect of the coffee melanoidin submitted to gastrointestinal digestion on cell viability (lactate dehydrogenase leakage) and redox status of cultured human hepatoma HepG2 cells submitted to oxidative stress induced by tert-butylhydroperoxide (t-BOOH). Concentration of reduced glutathione (GSH) and malondialdehyde (MDA), generation of reactive oxygen species (ROS) and activity of antioxidant enzymes glutathione peroxidase (GPx) and reductase (GR) were used as markers of cellular oxidative status. Pretreatment of cultured HepG2 cells with 0.5-10 microg/mL digested coffee melanoidin (DCM) for 2 or 20 h completely prevented the increase in cell damage and GR and partly prevented the decrease of GSH and the increase of MDA and GPx evoked by t-BOOH in HepG2 cells. In contrast, increased ROS generation induced by t-BOOH was not prevented when cells were pretreated with DCM. The results show that treatment of HepG2 cells with concentrations of DCM within the expected physiological range confers the cells a significant protection against an oxidative insult.     

山莴苣苦素改善FFA诱导的HepG2细胞脂肪变性及氧化应激的研究

目的:研究山莴苣苦素对游离脂肪酸(FFA)诱导的HepG2细胞脂肪变性的改善作用,并初步探讨其可能作用机制.方法:观察山莴苣苦素对HepG2细胞活力的影响.采用FFA诱导培养HepG2细胞,构建脂肪变性模型(NAFLD体外模型),并用山莴苣苦素干预72h后,检测各组细胞内脂滴数量、甘油三酯(TG)和总胆固醇(TC)含量...     

Protective effects of enzymatic digest from Ecklonia cava against high glucose‐induced oxidative stress in human umbilical vein endothelial cells

BACKGROUND: Antioxidants can prevent pathological damage caused by hyperglycaemia‐induced oxidative stress associated with diabetes. In the present study, we investigated whether the brown alga Ecklonia cava has protective effects against high glucose‐induced oxidative stress in Human umbilical vein endothelial cells (HUVECs). For that purpose, we prepared an enzymatic digest from E. cava (ECC) by using the carbohydrase, Celluclast. RESULTS: High glucose treatment induced HUVECs cell death, but ECC, at a concentration of 10 or 100 µg mL^?1, significantly inhibited the high glucose‐induced cytotoxicity. Furthermore, treatment with ECC dose‐dependently decreased thiobarbituric acid reactive substances (TBARS), intracellular generation of reactive oxygen species, and the nitric oxide level increased by high glucose. In addition, ECC treatment increased activities of antioxidant enzymes including catalase, superoxide dismutase and glutathione peroxidase in high‐glucose pretreated HUVECs. High glucose levels induced the overexpression of inducible nitric oxide synthase, cyclooxygenase‐2 and nuclear factor‐kappa B proteins in HUVECs, but ECC treatment reduced the overexpression of these proteins. CONCLUSION: These results suggest that ECC is a potential therapeutic agent that will reduce the damage caused by hyperglycaemia‐induced oxidative stress associated with diabetes. Copyright © 2009 Society of Chemical Industry